Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 244

Similar articles for PubMed (Select 17006916)

1.

Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study.

González A, Augustin S, Pérez M, Dot J, Saperas E, Tomasello A, Segarra A, Armengol JR, Malagelada JR, Esteban R, Guardia J, Genescà J.

Hepatology. 2006 Oct;44(4):806-12.

PMID:
17006916
2.

Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.

Villanueva C, Aracil C, Colomo A, Lopez-Balaguer JM, Piqueras M, Gonzalez B, Torras X, Guarner C, Balanzo J.

Aliment Pharmacol Ther. 2009 Feb 15;29(4):397-408. doi: 10.1111/j.1365-2036.2008.03880.x. Epub 2008 Nov 1.

PMID:
19006538
3.

Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy.

González A, Augustin S, Dot J, Pérez M, Abu-Suboh M, Romero A, Segarra A, Armengol JR, Esteban R, Guardia J, Genescà J.

Dig Liver Dis. 2012 Jan;44(1):55-60. doi: 10.1016/j.dld.2011.07.019. Epub 2011 Sep 3.

PMID:
21890439
4.

Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.

Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.

Gastroenterology. 2009 Jul;137(1):119-28. doi: 10.1053/j.gastro.2009.03.048. Epub 2009 Apr 1.

PMID:
19344721
5.

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.

Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, Gatta A.

Hepatology. 2000 Nov;32(5):930-4.

PMID:
11050041
6.
7.

Complications of cirrhosis. I. Portal hypertension.

Bosch J, García-Pagán JC.

J Hepatol. 2000;32(1 Suppl):141-56. Review.

PMID:
10728801
8.

Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.

Kravetz D.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S318-22. Review.

PMID:
17975483
9.

TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.

Escorsell A, Bañares R, García-Pagán JC, Gilabert R, Moitinho E, Piqueras B, Bru C, Echenagusia A, Granados A, Bosch J.

Hepatology. 2002 Feb;35(2):385-92.

PMID:
11826413
10.

Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding.

Augustin S, González A, Badia L, Millán L, Gelabert A, Romero A, Segarra A, Martell M, Esteban R, Guardia J, Genescà J.

Hepatology. 2012 Aug;56(2):706-14. doi: 10.1002/hep.25686. Epub 2012 Jul 6.

PMID:
22378235
11.

Variceal bleeding and portal hypertensive gastropathy.

Dagher L, Burroughs A.

Eur J Gastroenterol Hepatol. 2001 Jan;13(1):81-8. Review.

PMID:
11204818
12.

"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding.

Bureau C, Péron JM, Alric L, Morales J, Sanchez J, Barange K, Payen JL, Vinel JP.

Hepatology. 2002 Dec;36(6):1361-6.

PMID:
12447860
13.

Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.

Pomier-Layrargues G, Villeneuve JP, Deschênes M, Bui B, Perreault P, Fenyves D, Willems B, Marleau D, Bilodeau M, Lafortune M, Dufresne MP.

Gut. 2001 Mar;48(3):390-6.

14.

Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.

Sharma P, Kumar A, Sharma BC, Sarin SK.

Aliment Pharmacol Ther. 2009 Jul;30(1):48-60. doi: 10.1111/j.1365-2036.2009.04015.x. Epub 2009 Apr 8.

PMID:
19392862
15.

Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.

Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J.

J Hepatol. 2004 May;40(5):757-65.

PMID:
15094222
16.

Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.

García-Pagán JC, Villanueva C, Albillos A, Bañares R, Morillas R, Abraldes JG, Bosch J; Spanish Variceal Bleeding Study Group.

Gut. 2009 Aug;58(8):1144-50. doi: 10.1136/gut.2008.171207. Epub 2009 Feb 12.

PMID:
19218249
17.

Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation.

De BK, Sen S, Biswas PK, Sengupta D, Biswas J, Santra A, Hazra B, Maity AK.

Am J Gastroenterol. 2000 Aug;95(8):2023-8.

PMID:
10950052
18.

Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.

de la Peña J, Brullet E, Sanchez-Hernández E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suárez C.

Hepatology. 2005 Mar;41(3):572-8.

PMID:
15726659
19.
20.

Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial.

Gülberg V, Schepke M, Geigenberger G, Holl J, Brensing KA, Waggershauser T, Reiser M, Schild HH, Sauerbruch T, Gerbes AL.

Scand J Gastroenterol. 2002 Mar;37(3):338-43.

PMID:
11916197
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk